CureWise Launches AI-Powered Precision Oncology Platform at Aspen Ideas: Health 2026
Key Insights
CureWise (search), an AI-powered precision oncology platform, launched publicly at Aspen Ideas: Health 2026 to help cancer patients understand their unique disease biology and explore personalized treatment options.
Founder and CEO Steve Brown, himself a rare blood cancer (search) survivor, built the platform after using AI to identify targeted therapies beyond standard recommendations for his own diagnosis.
The platform merges medical records across health systems and cross-checks insights from leading AI models including Claude, Gemini, and ChatGPT to surface personalized treatment possibilities and clinical trials.
LOS ANGELES, June 22, 2026 — In a world where 200 million people globally use AI tools weekly for health-related questions, CureWise (search) founder and CEO Steve Brown will take the stage at Aspen Ideas: Health 2026 to launch the company's AI-powered precision oncology platform to the public. The platform is designed to bridge what Brown describes as a critical gap between the latest advances in cancer care and the life-changing questions many patients never know to ask.
Brown, who was diagnosed with a rare and aggressive blood cancer (search), turned to AI to better understand his disease, analyze his medical records, and explore whether more targeted treatment approaches existed beyond standard recommendations. That personal experience became the foundation for CureWise (search).
"When I was diagnosed, I had no idea how many treatment options might exist for my specific cancer," said Brown. "Science is moving faster than the healthcare system can deliver it, and patients are too often left to discover critical options on their own. That gap can change the course of someone's life."
A Platform Built on Personal Experience
CureWise (search) is built around the principles of precision medicine and is designed exclusively for cancer patients. Once patients connect their medical records, the platform securely merges health data from different health systems into a single, coherent picture of each patient's cancer journey. Using an AI approach that cross-checks perspectives from leading AI models — including Claude, Gemini, and ChatGPT — CureWise helps patients understand their unique cancer biology, explore personalized treatment possibilities, and identify relevant clinical trials matched to their specific biology.
Unlike general-purpose health platforms, CureWise (search) puts individuals at the center of their own care and equips them to advocate more effectively with their medical teams at every stage of their journey. "We built CureWise because no one should have to figure this out the hard way," Brown said. "Precision oncology is no longer a distant promise; it is real for more patients every day, but too many still never reach it."
Lisa Booth, CureWise (search) Vice President of Operations and an 11-year metastatic breast cancer (search) thriver, underscored the platform's patient-centered mission. "I spent years becoming my own chief scientist because I had no other choice. I flew across the country, read papers I only half understood, and still almost missed the drug that gave me seven more years of my life. No patient should have to work that hard to understand their own cancer. CureWise is how we fix that."
Privacy and Patient Agency at the Core
CureWise (search) is built with patient privacy as a foundational principle. Patient health data is fully patient-controlled, and information is never sold. The platform explains diagnoses, results, and options in plain language, cross-referencing the latest research and clinical trials to surface personalized treatment possibilities. The goal is to ensure patients walk into every oncology appointment prepared, clear on their options, and ready to participate fully in decisions about their own care.
"Knowledge is agency," the company states. "CureWise (search) makes that possible for every patient."
Leadership and Background
Brown brings extensive experience in health technology to the venture. He previously founded Health Hero Network, a pioneering remote monitoring system used by the Veterans Administration and the Centers for Medicare & Medicaid Services to help shape Medicare telehealth reimbursement. An inventor on more than 200 patents across AI, health monitoring, and behavioral science, Brown most recently served as chief AI officer for PHD Ventures and Abundance360 by Peter Diamandis.
Aspen Ideas: Health 2026 Session
Brown will speak on Wednesday, June 24, at 11:40 a.m. local time as part of "The Chatbot Will See You Now" session. He will be joined by Dhruv Khullar, Weill Cornell Medicine physician and writer for The New Yorker; Amelia Burke-Garcia, director of the Center for Health Communication Science at NORC, University of Chicago; and John Torres, NBC News medical contributor, who will moderate the discussion.
CureWise (search) was developed by patients navigating their own cancer journeys and clinicians who have spent their careers at the forefront of precision oncology, combining advanced AI systems with human-centered design to democratize access to precision cancer insights.